Loading...

BioStem Technologies, Inc.

BSEMPNK
Healthcare
Biotechnology
$11.64
$-0.22(-1.82%)

BioStem Technologies, Inc. (BSEM) Company Profile & Overview

Explore BioStem Technologies, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

BioStem Technologies, Inc. (BSEM) Company Profile & Overview

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

SectorHealthcare
IndustryBiotechnology
CEOJason V. Matuszewski

Contact Information

954 380 8342
2836 Center Port Circle, Pompano Beach, FL, 33064

Company Facts

2 Employees
IPO DateMar 17, 2015
CountryUS
Actively Trading

Frequently Asked Questions

;